 "Nifty hovers around 5,700 mark, capital goods gain")
Benchmark indices continue to trade marginally higher led by buying among capital goods and index heavyweight shares.
By 10:10, the Sensex was at 18,769 mark up 38 points whereas the Nifty gained by 11 points at 5,699 levels.
According to Ravi Nathani, technical analyst, Nsetoday.com, “Book profits on every rise as strong resistance for Nifty is expected around 5760, (fresh positional) traders best trading strategy would be sell on rise with a strict stoploss of 5760.”
Back home, the rupee today rose by 15 paise to 54.06 against the dollar in early trade on the Interbank Foreign Exchange as the US currency weakened against euro overseas amid a higher opening in the domestic equity market.
On the sectoral front, BSE Capital Goods, Healthcare, Power and Realty indices have surged by 1% each. However, BSE Metal, Bankex and IT indices are trading marginally lower.
Bharti Airtel is the top Sensex gainer, up over 3%. Other notable gainers include L&T, NTPC, BHEL, GAIL, HDFC, Sun Pharma, ITC, Tata Motors and M&M , all surging between 1-1.5%.
On the losing side, Hero Moto, ONGC, TCS and ICICI Bank have declined between 1-2%.
Tata Consultancy Services (TCS) is trading lower by 1.3% at Rs 1,440 in early morning deals after reporting 1.9% quarter-on-quarter growth in its consolidated net profit at Rs 3,597 crore for January-March quarter (Q4). Analysts, on an average, had expected profit of Rs 3,563 crore from the country's largest software exporter.
Among other shares, Orchid Chemicals and Pharmaceuticals are trading higher by almost 4% to Rs 69.10, extending its previous day’s 5% rally after the company said Cephalosporin API manufacturing complex located in Alathur has cleared the US Food and Drug Administration (USFDA) inspection.
Gayatri Projects has soared 13.5% to Rs 77.95 after the company said its arm has executed power purchase agreement (PPA) with Andhra Pradesh government for its 1,320 MW power plant in the state.
The market breadth in BSE remains positive with 805 shares advancing and 484 shares declining.
By 10:10, the Sensex was at 18,769 mark up 38 points whereas the Nifty gained by 11 points at 5,699 levels.
According to Ravi Nathani, technical analyst, Nsetoday.com, “Book profits on every rise as strong resistance for Nifty is expected around 5760, (fresh positional) traders best trading strategy would be sell on rise with a strict stoploss of 5760.”
More From This Section
On the global front, Asian shares inched lower on Thursday, taking their cues from an overnight drop in US and European equities on renewed concerns about global growth, which also weighed on commodities. The MSCI's broadest index of Asia-Pacific shares outside Japan was down 0.3%, with Australian shares falling 0.4%, hit by sinking copper prices which deepened concerns about demand for Australia's raw materials.
Back home, the rupee today rose by 15 paise to 54.06 against the dollar in early trade on the Interbank Foreign Exchange as the US currency weakened against euro overseas amid a higher opening in the domestic equity market.
On the sectoral front, BSE Capital Goods, Healthcare, Power and Realty indices have surged by 1% each. However, BSE Metal, Bankex and IT indices are trading marginally lower.
Bharti Airtel is the top Sensex gainer, up over 3%. Other notable gainers include L&T, NTPC, BHEL, GAIL, HDFC, Sun Pharma, ITC, Tata Motors and M&M , all surging between 1-1.5%.
On the losing side, Hero Moto, ONGC, TCS and ICICI Bank have declined between 1-2%.
Tata Consultancy Services (TCS) is trading lower by 1.3% at Rs 1,440 in early morning deals after reporting 1.9% quarter-on-quarter growth in its consolidated net profit at Rs 3,597 crore for January-March quarter (Q4). Analysts, on an average, had expected profit of Rs 3,563 crore from the country's largest software exporter.
Among other shares, Orchid Chemicals and Pharmaceuticals are trading higher by almost 4% to Rs 69.10, extending its previous day’s 5% rally after the company said Cephalosporin API manufacturing complex located in Alathur has cleared the US Food and Drug Administration (USFDA) inspection.
Gayatri Projects has soared 13.5% to Rs 77.95 after the company said its arm has executed power purchase agreement (PPA) with Andhra Pradesh government for its 1,320 MW power plant in the state.
The market breadth in BSE remains positive with 805 shares advancing and 484 shares declining.